Get the detailed quarterly/annual income statement for Arbutus Biopharma Corporation (ABUS). Find out the revenue, expenses and profit or loss over the last fiscal year.

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Arbutus ...

This piece first appeared in the June edition of BikeBiz magazine – not subscribed? Get a free subscription. What goes into making a helmet? Passion, determination, teamwork? It’s easy to forget how ...

Arbutus Biopharma (ABUS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.11 per share a year ago.

Abus has updated its Airbreaker helmet, saying the Airbreaker 2.0 combines good ventilation with aerodynamics, borrowing its basic structure from the brand’s aero Gamechanger helmet. New features ...

Arbutus Biopharma just announced another significant restructuring, including layoffs and management changes, to reduce cash burn and streamline operations. The company is now focused on developing ...

It's almost impossible not to attach a level of romanticism to the life of a trucker, as life on the road presents no shortage of sights that go largely unseen by the general public. But there are ...

People who know Naledi are perpetually aware of two things: he is a talented visual artist, and he has seen copious amounts of anime. Where To Watch Every Spring 2025 Anime Series Where To Watch Every ...

Tesla and Eaton, a giant multinational manufacturer focused on intelligent power management, are partnering to improve Powerwall integration with the latter’s smart breakers. At the RE+ 24, a clean ...

Arbutus Biopharma Corp (NASDAQ: ABUS) and its partner Genevant Sciences have reached an agreement with Moderna , Inc. (NASDAQ: MRNA) to postpone a patent infringement trial related to Moderna's ...